151 related articles for article (PubMed ID: 14717966)
21. Plasma thrombin-activatable fibrinolysis inhibitor and the 1040C/T polymorphism are risk factors for diabetic kidney disease in Chinese patients with type 2 diabetes.
Huang Q; Feng D; Pan L; Wang H; Wu Y; Zhong B; Gong J; Lin H; Fei X
PeerJ; 2023; 11():e16352. PubMed ID: 38025709
[TBL] [Abstract][Full Text] [Related]
22. Association of TAFI gene polymorphisms with severity of coronary stenosis in stable coronary artery disease.
Rattanawan C; Komanasin N; Settasatian N; Settasatian C; Kukongviriyapan U; Intharapetch P; Senthong V
Thromb Res; 2018 Nov; 171():171-176. PubMed ID: 30321704
[TBL] [Abstract][Full Text] [Related]
23. Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.
Schneider M; Boffa M; Stewart R; Rahman M; Koschinsky M; Nesheim M
J Biol Chem; 2002 Jan; 277(2):1021-30. PubMed ID: 11684677
[TBL] [Abstract][Full Text] [Related]
24. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
Antovic JP; Blombäck M
Thromb Res; 2002 Apr; 106(1):59-62. PubMed ID: 12165290
[TBL] [Abstract][Full Text] [Related]
25. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis.
Miljić P; Heylen E; Willemse J; Djordjević V; Radojković D; Colović M; Elezović I; Hendriks D
Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():74-8. PubMed ID: 20229688
[TBL] [Abstract][Full Text] [Related]
26. Generation of a stable activated thrombin activable fibrinolysis inhibitor variant.
Ceresa E; Van de Borne K; Peeters M; Lijnen HR; Declerck PJ; Gils A
J Biol Chem; 2006 Jun; 281(23):15878-83. PubMed ID: 16595693
[TBL] [Abstract][Full Text] [Related]
27. Thrombin-activatable fibrinolysis inhibitor (TAFI) levels and its polymorphism rs3742264 are associated with dyslipidemia in a cohort of Brazilian subjects.
Santos IR; Fernandes AP; Carvalho MG; Sousa MO; Ferreira CN; Gomes KB
Clin Chim Acta; 2014 Jun; 433():76-83. PubMed ID: 24631134
[TBL] [Abstract][Full Text] [Related]
28. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.
Zhou X; Weeks SD; Ameloot P; Callewaert N; Strelkov SV; Declerck PJ
J Thromb Haemost; 2016 Aug; 14(8):1629-38. PubMed ID: 27279497
[TBL] [Abstract][Full Text] [Related]
29. [Correlation analysis of thrombin-activatable fibrinolysis inhibitor single nucleotide polymorphism with venous thromboembolism].
Li C; Hou LH; Liu XE; Huang C; Wei XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):949-53. PubMed ID: 22931662
[TBL] [Abstract][Full Text] [Related]
30. Plasma levels of unactivated thrombin activatable fibrinolysis inhibitor (TAFI) are down-regulated in young adult women: analysis of a normal Japanese population.
Akatsu H; Ishiguro M; Ogawa N; Kanesaka T; Okada N; Yamamoto T; Campbell W; Okada H
Microbiol Immunol; 2007; 51(5):507-17. PubMed ID: 17579260
[TBL] [Abstract][Full Text] [Related]
31. Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension.
Yaoita N; Satoh K; Satoh T; Sugimura K; Tatebe S; Yamamoto S; Aoki T; Miura M; Miyata S; Kawamura T; Horiuchi H; Fukumoto Y; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1293-301. PubMed ID: 27102961
[TBL] [Abstract][Full Text] [Related]
32. Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme.
Garabon JJW; Boffa MB
J Thromb Thrombolysis; 2023 Aug; 56(2):283-290. PubMed ID: 37310666
[TBL] [Abstract][Full Text] [Related]
33. Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease.
Bridge KI; Bollen L; Zhong J; Hesketh M; Macrae FL; Johnson A; Philippou H; Scott DJ; Gils A; Ariёns RAS
J Thromb Haemost; 2017 Nov; 15(11):2218-2225. PubMed ID: 28834317
[TBL] [Abstract][Full Text] [Related]
34. Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis.
Incampo F; Carrieri C; Galasso R; Scaraggi FA; Di Serio F; Woodhams B; Semeraro N; Colucci M
J Thromb Haemost; 2013 Feb; 11(2):315-24. PubMed ID: 23256818
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies targeting the antifibrinolytic activity of activated thrombin-activatable fibrinolysis inhibitor but not the anti-inflammatory activity on osteopontin and C5a.
Semeraro F; Ammollo CT; Gils A; Declerck PJ; Colucci M
J Thromb Haemost; 2013 Dec; 11(12):2137-47. PubMed ID: 24134522
[TBL] [Abstract][Full Text] [Related]
36. Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia.
Meijers JC; Oudijk EJ; Mosnier LO; Bos R; Bouma BN; Nieuwenhuis HK; Fijnheer R
Br J Haematol; 2000 Mar; 108(3):518-23. PubMed ID: 10759708
[TBL] [Abstract][Full Text] [Related]
37. Association between polymorphisms in the flanking region of the TAFI gene and atherosclerotic cerebral infarction in a Chinese population.
Li Y; Zeng Z; Zhao J; Ma G; Cui L; Tao H; Lin Z; Chen Y; Zhao B; Chen Y; Li K
Lipids Health Dis; 2014 May; 13():80. PubMed ID: 24886076
[TBL] [Abstract][Full Text] [Related]
38. Genetic variations in the thrombin-activatable fibrinolysis inhibitor gene and risk of cardiovascular disease: a systematic review and meta-analysis.
Shi J; Zhi P; Chen J; Wu P; Tan S
Thromb Res; 2014 Sep; 134(3):610-6. PubMed ID: 25042727
[TBL] [Abstract][Full Text] [Related]
39. Thrombin-Activatable Fibrinolysis Inhibitor Gene Polymorphism (TAFI1040C/T) in Women With Recurrent Spontaneous Abortion.
ElDanasori N; Abulata N; Shaheen IA; ElGendy AM; El-Khayat W
Clin Appl Thromb Hemost; 2018 Apr; 24(3):532-535. PubMed ID: 28301909
[TBL] [Abstract][Full Text] [Related]
40. Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides.
Plug T; Marquart JA; Marx PF; Meijers JC
J Thromb Haemost; 2015 Nov; 13(11):2093-101. PubMed ID: 26341360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
